Subtotal parathyroid resection is indicated when secondary or tertiary hyperparathyroidism (HPT) develops and may be indicated also in patients with primary HPT and multiglandular disease. Three different surgical procedures are used to treat diffuse parathyroid hyperplasia: total parathyroidectomy with or without autotransplantation, and subtotal parathyroidectomy. One of the main complications is transient or persistent hypoparathyroidism. In this video, we show our technique of subtotal parathyroidectomy using a fluorescent dye (indocyanine green [ICG]) to check for the vascularization of the parathyroid remnant, to avoid definitive postoperative hypoparathyroidism. We present a 64-year-old man with end-stage chronic kidney disease dialyzed since 2008. His parathyroid hormone (PTH) level was 106 pmol/L, corrected calcium level was 2.29 mmol/L and phosphate 1.63 mmol/L under maximal medical treatment, and he had significant bone disease. A subtotal parathyroidectomy was scheduled. After reclining pre-thyroid muscles, we medialized the right thyroid lobe to expose the right parathyroid glands. The superior one was a good candidate to be preserved partially because it looked hyperplastic, but without a macroscopic nodule and was the smallest of the four parathyroid glands. The inferior one was located deep in the mediastinum, in the thymus, and was therefore not suitable for subtotal resection. The procedure was the same for the left side. The inferior parathyroid gland harbored nodular hyperplasia and, therefore, was not very suitable for partial resection, but the superior one looked as a good candidate for subtotal resection too. We started reducing the volume of the parathyroid glands with clips, preserving carefully each parathyroid's vascular pedicle. Then, we intravenously injected 3.5 mL of indocyanine green solution to check the perfusion of the parathyroid remnant, using a fluorescent imaging camera (PINPOINT camera; Novadaq, Mississauga, ON, Canada). The perfusion can be seen as green or white, depending on the selected image mode. We finally chose the right superior parathyroid gland and resected the gland outside of the clips. The other glands have finally been entirely removed. The postoperative course was uneventful except for hypocalcemia needing intravenous calcium for 48 hours. On the first postoperative day, corrected calcium level was 1.93 mmol/L and PTH level was 8 pmol/L. The two inferior parathyroid glands showed nodular hyperplasia at pathologic examination and the two superior glands showed diffuse hyperplasia without nodules. With this new procedure, subtotal parathyroidectomy under ICG angiography, we can check for the good vascularization of the parathyroid remnant before resecting the other parathyroid glands. Therefore, we can intraoperatively guarantee the absence of definitive hypoparathyroidism. This technique is safe, reproducible, and its easy use makes it the procedure of choice in these situations, when the device is available. No competing financial interests exist. Runtime of video: 6 mins 33 secs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961799 | PMC |
http://dx.doi.org/10.1089/ve.2015.0056 | DOI Listing |
Rev Med Chil
May 2024
Departamento de Nefrología, Clínica Dávila, Santiago, Chile.
Int J Surg Case Rep
December 2024
Department of Otorhinolaryngology, Aarhus University Hospital, Aarhus N, Denmark.
Introduction And Importance: Primary hyperparathyroidism (PHPT) is a frequent complication to multiple endocrine neoplasia type 1 (MEN1), presenting challenges due to increased risk of multi-gland disease and recurrence post parathyroidectomy (PTX). This case report examines the management of PHPT in a MEN1 patient, emphasizing possible benefits from intraoperative parathyroid autofluorescence imaging (AF).
Case Presentation: A 21-year-old woman with MEN1 presented with mild hyperparathyroidism symptoms in 2014.
Cureus
November 2024
Nephrology, Colchester Hospital, Colchester, GBR.
Calciphylaxis is a rare and serious disorder almost exclusively seen in patients on dialysis or those with advanced chronic kidney disease (CKD) not on dialysis and is associated with very high mortality. We present the case of a 50-year-old male with a background of end-stage renal disease (ESRD) compliant with dialysis, parathyroid adenoma, secondary hyperparathyroidism, and high body mass index (BMI). Whilst receiving 31 doses of intravenous sodium thiosulphate (STS) over an 11-week period, the patient underwent surgical debridement of multiple painful ulcerative lesions in his lower abdomen and left thigh and then subsequently a subtotal parathyroidectomy at 70 days from admission.
View Article and Find Full Text PDFCase Rep Endocrinol
December 2024
Henry Ford St. John Hospital, Detroit, Michigan, USA.
Surgery
January 2025
Department of Surgery, Temple University Lewis Katz School of Medicine, Philadelphia, PA.
Background: Hyperparathyroidism is common among patients with chronic kidney disease, end-stage kidney disease, and kidney transplant. The American Association for Endocrine Surgery published clinical practice guidelines that address the surgical treatment of secondary and tertiary hyperparathyroidism. The purpose of this study is to determine practice patterns for the surgical management of secondary and tertiary hyperparathyroidism prior to guideline publication.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!